CMG Pharmaceutical Co. Ltd (058820) - Total Liabilities

Latest as of December 2025: ₩104.41 Billion KRW ≈ $70.75 Million USD

Based on the latest financial reports, CMG Pharmaceutical Co. Ltd (058820) has total liabilities worth ₩104.41 Billion KRW (≈ $70.75 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CMG Pharmaceutical Co. Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how CMG Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore CMG Pharmaceutical Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

CMG Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of CMG Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
FineMat Applied Materials Co Ltd TW:6698	Taiwan	NT$963.77 Million
St. James's Place plc LSE:STJ	UK	GBX223.16 Billion
Austin Engineering Ltd AU:ANG	Australia	AU$133.20 Million
Sheh Fung Screws Co Ltd TWO:2065	Taiwan	NT$1.61 Billion
Vakrangee Limited NSE:VAKRANGEE	India	Rs1.25 Billion
Algoltek Inc TWO:6684	Taiwan	NT$138.32 Million
DY Corporation KO:013570	Korea	₩448.43 Billion
Intiland Development Tbk JK:DILD	Indonesia	Rp6.17 Trillion

Liability Composition Analysis (2011–2025)

This chart breaks down CMG Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CMG Pharmaceutical Co. Ltd asset portfolio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.52	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.34	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CMG Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CMG Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual total liabilities of CMG Pharmaceutical Co. Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩104.41 Billion ≈ $70.75 Million	-8.33%
2024-12-31	₩113.89 Billion ≈ $77.18 Million	+119.60%
2023-12-31	₩51.87 Billion ≈ $35.15 Million	+83.22%
2022-12-31	₩28.31 Billion ≈ $19.18 Million	+95.60%
2021-12-31	₩14.47 Billion ≈ $9.81 Million	+1.74%
2020-12-31	₩14.22 Billion ≈ $9.64 Million	+17.71%
2019-12-31	₩12.08 Billion ≈ $8.19 Million	+16.22%
2018-12-31	₩10.40 Billion ≈ $7.05 Million	-10.55%
2017-12-31	₩11.62 Billion ≈ $7.88 Million	+17.75%
2016-12-31	₩9.87 Billion ≈ $6.69 Million	+1.50%
2015-12-31	₩9.73 Billion ≈ $6.59 Million	+7.28%
2014-12-31	₩9.07 Billion ≈ $6.14 Million	+31.10%
2013-12-31	₩6.92 Billion ≈ $4.69 Million	-72.90%
2012-12-31	₩25.52 Billion ≈ $17.29 Million	+175.24%
2011-12-31	₩9.27 Billion ≈ $6.28 Million	--

About CMG Pharmaceutical Co. Ltd

KQ:058820 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$70.53 Million

₩104.08 Billion KRW

Market Cap Rank

#20616 Global

#1138 in Korea

Share Price

₩704.00

Change (1 day)

-1.54%

52-Week Range

₩695.00 - ₩2140.00

All Time High

₩8318.64